SUREKHA GORANTLA: Open Payments
NPI 1144548660 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $86 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| CSL Behring | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
Products named: DUPIXENT, TEZSPIRE, Hizentra, XHANCE, Rhapsido, BREZTRI, NEFFY.
Industry payments across MD — which companies pay providers there.
